{"id":"carboplatin-thiotepa-and-cyclophosphamide","safety":{"commonSideEffects":[{"rate":"20-50%","effect":"Myelosuppression"},{"rate":"30-60%","effect":"Nausea and vomiting"},{"rate":"20-40%","effect":"Hair loss"},{"rate":"20-40%","effect":"Fatigue"},{"rate":"10-30%","effect":"Infection"}]},"_chembl":{"chemblId":"CHEMBL1351","moleculeType":"Small molecule","molecularWeight":"371.25"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Carboplatin is a platinum-based alkylating agent that forms platinum-DNA adducts, causing DNA damage and apoptosis. Thiotepa is a nitrogen mustard alkylating agent that cross-links DNA, also leading to cell death. Cyclophosphamide is an alkylating agent that forms DNA cross-links and interstrand cross-links, causing DNA damage and cell death.","oneSentence":"Carboplatin, thiotepa, and cyclophosphamide work by interfering with DNA replication and function, leading to cell death in rapidly dividing cancer cells.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:42:25.950Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Ovarian cancer"},{"name":"Breast cancer"},{"name":"Lung cancer"}]},"trialDetails":[{"nctId":"NCT06172296","phase":"PHASE3","title":"Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-04-19","conditions":"Ganglioneuroblastoma, Nodular, Neuroblastoma","enrollment":478},{"nctId":"NCT06193759","phase":"PHASE1","title":"Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)","status":"RECRUITING","sponsor":"Children's National Research Institute","startDate":"2024-09-20","conditions":"Medulloblastoma, Childhood, Atypical Teratoid/Rhabdoid Tumor of CNS, Embryonal Tumor With Multilayered Rosettes","enrollment":12},{"nctId":"NCT03126916","phase":"PHASE3","title":"Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2018-05-14","conditions":"Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular, Neuroblastoma","enrollment":750},{"nctId":"NCT06942039","phase":"EARLY_PHASE1","title":"Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation","status":"RECRUITING","sponsor":"C17 Council","startDate":"2025-09-23","conditions":"CNS Embryonal Tumor, CNS, Medulloblastoma, Atypical Teratoid Rhabdoid Tumor","enrollment":15},{"nctId":"NCT04684368","phase":"PHASE2","title":"A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2021-07-13","conditions":"Central Nervous System Nongerminomatous Germ Cell Tumor, Choriocarcinoma, Embryonal Carcinoma","enrollment":160},{"nctId":"NCT02875314","phase":"PHASE4","title":"HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Parth Patel","startDate":"2015-09","conditions":"Medulloblastoma, Central Nervous System Embryonal Tumors","enrollment":250},{"nctId":"NCT00336024","phase":"PHASE3","title":"Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2007-10-22","conditions":"Anaplastic Medulloblastoma, Medulloblastoma, Supratentorial Embryonal Tumor, Not Otherwise Specified","enrollment":91},{"nctId":"NCT02870907","phase":"PHASE2","title":"Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Institut Curie","startDate":"2010-03-18","conditions":"Retinoblastoma","enrollment":195},{"nctId":"NCT06861244","phase":"PHASE2","title":"Embryonal Tumor With Multilayered Rosettes","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2025-03-06","conditions":"Embryonal Tumor With Multilayered Rosettes, Embryonal Tumor With Multilayered Rosettes, Nos","enrollment":70},{"nctId":"NCT07291102","phase":"PHASE3","title":"Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma","status":"NOT_YET_RECRUITING","sponsor":"Nationwide Children's Hospital","startDate":"2026-07-01","conditions":"Medulloblastoma","enrollment":96},{"nctId":"NCT02810743","phase":"PHASE3","title":"Substantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Netherlands Cancer Institute","startDate":"2017-01-25","conditions":"Breast Cancer","enrollment":174},{"nctId":"NCT02605421","phase":"PHASE2","title":"Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma","status":"RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2016-06","conditions":"Neuroblastoma","enrollment":12},{"nctId":"NCT03786783","phase":"PHASE2","title":"Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-03-04","conditions":"Ganglioneuroblastoma, High Risk Neuroblastoma","enrollment":42},{"nctId":"NCT02329080","phase":"PHASE2","title":"New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement","status":"COMPLETED","sponsor":"International Extranodal Lymphoma Study Group (IELSG)","startDate":"2014-12","conditions":"Diffuse Large B-cell Lymphoma","enrollment":79},{"nctId":"NCT04221035","phase":"PHASE3","title":"High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)","status":"RECRUITING","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2019-11-05","conditions":"High-Risk Neuroblastoma, Patient With Insufficient Response Chemoimmunotherapy","enrollment":800},{"nctId":"NCT00554788","phase":"PHASE3","title":"Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2008-05-06","conditions":"Extraocular Retinoblastoma","enrollment":60},{"nctId":"NCT00653068","phase":"PHASE3","title":"Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2009-02-10","conditions":"Childhood Atypical Teratoid/Rhabdoid Tumor","enrollment":70},{"nctId":"NCT01505569","phase":"NA","title":"Auto Transplant for High Risk or Relapsed Solid or CNS Tumors","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2011-10-20","conditions":"Ewing's Family Tumors, Renal Tumors, Hepatoblastoma","enrollment":44},{"nctId":"NCT01057069","phase":"PHASE2, PHASE3","title":"Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Netherlands Cancer Institute","startDate":"2010-01","conditions":"Breast Cancer","enrollment":310},{"nctId":"NCT01646034","phase":"PHASE3","title":"High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Netherlands Cancer Institute","startDate":"2014-09","conditions":"Breast Cancer","enrollment":74},{"nctId":"NCT00432094","phase":"PHASE2","title":"Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2006-12-19","conditions":"Childhood Germ Cell Tumor, Ovarian Cancer, Teratoma","enrollment":23},{"nctId":"NCT00567567","phase":"PHASE3","title":"Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2007-11-05","conditions":"Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Recurrent Neuroblastoma","enrollment":665},{"nctId":"NCT00867178","phase":"PHASE1","title":"Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2009-02-25","conditions":"Medulloblastoma, Pineoblastoma, Supratentorial Embryonal Tumor, Not Otherwise Specified","enrollment":33},{"nctId":"NCT00003816","phase":"PHASE2, PHASE3","title":"Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer","status":"COMPLETED","sponsor":"Roswell Park Cancer Institute","startDate":"1998-10-19","conditions":"Chronic Myeloproliferative Disorders, Leukemia, Lymphoma","enrollment":361},{"nctId":"NCT00536601","phase":"NA","title":"High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors","status":"COMPLETED","sponsor":"Roswell Park Cancer Institute","startDate":"2006-06-29","conditions":"Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities","enrollment":174},{"nctId":"NCT00448266","phase":"PHASE2, PHASE3","title":"Intensified IAA With PBPC Support in Breast Tumors With Evidence of a HRD","status":"TERMINATED","sponsor":"The Netherlands Cancer Institute","startDate":"2007-05","conditions":"Breast Cancer","enrollment":12},{"nctId":"NCT00179803","phase":"PHASE2","title":"Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors","status":"COMPLETED","sponsor":"Ann & Robert H Lurie Children's Hospital of Chicago","startDate":"1998-03","conditions":"Glioblastoma, Astrocytoma, Pineoblastoma","enrollment":24},{"nctId":"NCT00003086","phase":"PHASE1, PHASE2","title":"Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer","status":"TERMINATED","sponsor":"Louisiana State University Health Sciences Center Shreveport","startDate":"1997-03","conditions":"Breast Cancer","enrollment":12},{"nctId":"NCT02784054","phase":"PHASE2","title":"Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell Tumor","status":"UNKNOWN","sponsor":"Samsung Medical Center","startDate":"2014-04","conditions":"Intracranial Non-germinomatous Germ Cell Tumor","enrollment":25},{"nctId":"NCT01091168","phase":"PHASE3","title":"Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer","status":"COMPLETED","sponsor":"Pierre Fabre Medicament","startDate":"2009-07","conditions":"Breast Cancer, Metastases","enrollment":594},{"nctId":"NCT00003194","phase":"PHASE1","title":"Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors","status":"TERMINATED","sponsor":"Seattle Children's Hospital","startDate":"1997-07","conditions":"Unspecified Childhood Solid Tumor, Protocol Specific","enrollment":24},{"nctId":"NCT00793845","phase":"PHASE2","title":"Tandem High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients With High-risk Neuroblastoma","status":"COMPLETED","sponsor":"Samsung Medical Center","startDate":"2008-08","conditions":"Neuroblastoma","enrollment":40},{"nctId":"NCT03061656","phase":"PHASE2","title":"Tandem High Dose Chemotherapy With 131I-MIBG Treatment in High Risk Neuroblastoma","status":"UNKNOWN","sponsor":"Samsung Medical Center","startDate":"2009-01-01","conditions":"High Risk Neuroblastoma","enrollment":40},{"nctId":"NCT02784015","phase":"PHASE2","title":"Response Based Treatment for Children With Unresectable Localized Soft Tissue Sarcoma","status":"UNKNOWN","sponsor":"Samsung Medical Center","startDate":"2016-05","conditions":"Unresectable Localized Soft Tissue Sarcoma","enrollment":41},{"nctId":"NCT00002942","phase":"PHASE3","title":"Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"1996-06","conditions":"Breast Cancer","enrollment":136},{"nctId":"NCT00006123","phase":"PHASE1, PHASE2","title":"Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer","status":"WITHDRAWN","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2000-07","conditions":"Breast Cancer","enrollment":""},{"nctId":"NCT00047320","phase":"PHASE2","title":"Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2004-01","conditions":"Brain Tumor, Central Nervous System Tumors, Childhood Germ Cell Tumor","enrollment":104},{"nctId":"NCT00182793","phase":"PHASE2","title":"Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer","status":"COMPLETED","sponsor":"City of Hope Medical Center","startDate":"2005-07","conditions":"Breast Cancer","enrollment":32},{"nctId":"NCT00003852","phase":"PHASE2","title":"Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors","status":"TERMINATED","sponsor":"UNICANCER","startDate":"1998-03","conditions":"Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Ovarian Cancer","enrollment":45},{"nctId":"NCT00020722","phase":"PHASE2","title":"Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer","status":"TERMINATED","sponsor":"Barbara Ann Karmanos Cancer Institute","startDate":"2007-08","conditions":"Breast Cancer","enrollment":7},{"nctId":"NCT00003273","phase":"PHASE2","title":"Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor","status":"WITHDRAWN","sponsor":"NYU Langone Health","startDate":"1997-11","conditions":"Brain and Central Nervous System Tumors, Neuroblastoma, Retinoblastoma","enrollment":""},{"nctId":"NCT00317408","phase":"NA","title":"Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma","status":"UNKNOWN","sponsor":"European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin Lymphoma","startDate":"2004-04","conditions":"Lymphoma","enrollment":96},{"nctId":"NCT00004092","phase":"PHASE2","title":"Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer","status":"COMPLETED","sponsor":"City of Hope Medical Center","startDate":"1999-05","conditions":"Breast Cancer","enrollment":72},{"nctId":"NCT00003846","phase":"PHASE2","title":"Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1999-07","conditions":"Brain and Central Nervous System Tumors, Neuroblastoma","enrollment":25},{"nctId":"NCT00003141","phase":"PHASE1","title":"Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1998-03","conditions":"Brain Tumors, Central Nervous System Tumors, Neuroblastoma","enrollment":94},{"nctId":"NCT00017368","phase":"PHASE2","title":"Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2001-04","conditions":"Neuroblastoma","enrollment":42},{"nctId":"NCT00303810","phase":"NA","title":"Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma","status":"COMPLETED","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2001-01","conditions":"Brain and Central Nervous System Tumors","enrollment":567},{"nctId":"NCT00012311","phase":"PHASE2","title":"Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer","status":"UNKNOWN","sponsor":"Herbert Irving Comprehensive Cancer Center","startDate":"2000-01","conditions":"Breast Cancer","enrollment":""},{"nctId":"NCT00002780","phase":"PHASE1, PHASE2","title":"Biological Therapy in Treating Women With Metastatic Breast Cancer","status":"UNKNOWN","sponsor":"St. Luke's Medical Center","startDate":"1996-05","conditions":"Breast Cancer","enrollment":60},{"nctId":"NCT00025324","phase":"PHASE2","title":"Chemotherapy, Surgery, Radiation Therapy and Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Primary CNS Germ Cell Tumors","status":"UNKNOWN","sponsor":"Children's Hospital Los Angeles","startDate":"2000-12","conditions":"Brain and Central Nervous System Tumors","enrollment":""},{"nctId":"NCT00392886","phase":"PHASE3","title":"Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors","status":"UNKNOWN","sponsor":"Children's Hospital Los Angeles","startDate":"2004-03","conditions":"Brain and Central Nervous System Tumors","enrollment":120},{"nctId":"NCT00002616","phase":"PHASE1","title":"Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer","status":"UNKNOWN","sponsor":"University of Illinois at Chicago","startDate":"1995-02","conditions":"Breast Cancer","enrollment":36},{"nctId":"NCT00003412","phase":"PHASE1","title":"Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell Transplantation","status":"UNKNOWN","sponsor":"Beth Israel Deaconess Medical Center","startDate":"1998-06","conditions":"Breast Cancer","enrollment":35},{"nctId":"NCT00025077","phase":"PHASE2","title":"Combination Chemotherapy, Surgery or Radiation Therapy, and Peripheral Stem Cell Transplant in Treating Patients With Recurrent Medulloblastoma or Primitive Neuroectodermal and Pineal Tumors","status":"COMPLETED","sponsor":"Children's Cancer and Leukaemia Group","startDate":"2000-01","conditions":"Brain and Central Nervous System Tumors","enrollment":50},{"nctId":"NCT00004900","phase":"PHASE2","title":"Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer","status":"COMPLETED","sponsor":"Hackensack Meridian Health","startDate":"1999-10","conditions":"Breast Cancer","enrollment":""},{"nctId":"NCT00004906","phase":"PHASE2","title":"Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer","status":"COMPLETED","sponsor":"Hackensack Meridian Health","startDate":"1999-10","conditions":"Breast Cancer","enrollment":""},{"nctId":"NCT00060255","phase":"PHASE2","title":"High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors","status":"COMPLETED","sponsor":"Roswell Park Cancer Institute","startDate":"1991-12","conditions":"Breast Cancer, Leukemia, Lymphoma","enrollment":451},{"nctId":"NCT00429182","phase":"PHASE2","title":"Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2007-06","conditions":"Breast Cancer, Metastatic Breast Carcinoma, Invasive Breast Carcinoma","enrollment":32},{"nctId":"NCT00040872","phase":"PHASE2","title":"Multiple Therapies in Treating Patients With Advanced Neuroblastoma","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2000-06","conditions":"Neuroblastoma","enrollment":""},{"nctId":"NCT00008203","phase":"PHASE3","title":"Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer","status":"COMPLETED","sponsor":"Herbert Irving Comprehensive Cancer Center","startDate":"1996-05","conditions":"Breast Cancer","enrollment":""},{"nctId":"NCT00002772","phase":"PHASE3","title":"S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer","status":"TERMINATED","sponsor":"SWOG Cancer Research Network","startDate":"1996-07","conditions":"Breast Cancer","enrollment":602},{"nctId":"NCT00005798","phase":"PHASE2","title":"Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer","status":"COMPLETED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"1995-07","conditions":"Breast Cancer","enrollment":209},{"nctId":"NCT00004172","phase":"PHASE2","title":"Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer","status":"COMPLETED","sponsor":"Northwestern University","startDate":"1999-10","conditions":"Breast Cancer","enrollment":""},{"nctId":"NCT00003877","phase":"PHASE1, PHASE2","title":"Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer","status":"COMPLETED","sponsor":"Roswell Park Cancer Institute","startDate":"1998-09","conditions":"Breast Cancer","enrollment":30},{"nctId":"NCT00003972","phase":"PHASE3","title":"Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"1998-07","conditions":"Breast Cancer","enrollment":280},{"nctId":"NCT00851110","phase":"PHASE2","title":"Adjuvant Breast Cancer Study of the Netherlands Working Party for Autotransplantation in Solid Tumors","status":"TERMINATED","sponsor":"University Medical Center Groningen","startDate":"2004-10","conditions":"High-Risk Breast Cancer","enrollment":50}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":48,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"carboplatin, thiotepa, and cyclophosphamide","genericName":"carboplatin, thiotepa, and cyclophosphamide","companyName":"The Netherlands Cancer Institute","companyId":"the-netherlands-cancer-institute","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Carboplatin, thiotepa, and cyclophosphamide work by interfering with DNA replication and function, leading to cell death in rapidly dividing cancer cells. Used for Ovarian cancer, Breast cancer, Lung cancer.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}